Adjuvant anti-HER2 monoclonal antibody therapy – ready for breast cancer?
Open Access
- 1 August 2001
- journal article
- Published by Elsevier in The Breast
- Vol. 10, 161-163
- https://doi.org/10.1016/s0960-9776(16)30026-1
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- HER2 and Choice of Adjuvant Chemotherapy for Invasive Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15JNCI Journal of the National Cancer Institute, 2000
- HER-2 as a Prognostic, Predictive, and Therapeutic Target in Breast CancerCancer Control, 1999